Effect of prior treatments on selinexor, bortezomib, and dexamethasone in previously treated multiple myeloma
Therapeutic regimens for previously treated multiple myeloma (MM) may not provide prolonged disease control and are often complicated by significant adverse events, including peripheral neuropathy. In patients...
Source: Journal of Hematology and Oncology - Category: Hematology Authors: Maria V. Mateos, Maria Gavriatopoulou, Thierry Facon, Holger W. Auner, Xavier Leleu, Roman H ájek, Meletios A. Dimopoulos, Sosana Delimpasi, Maryana Simonova, Ivan Špička, Ludĕk Pour, Iryna Kriachok, Halyna Pylypenko, Vadim Doronin, Ganna Usenko, Reub Tags: Letter to the Editor Source Type: research
More News: Brain | Cancer & Oncology | Dexamethasone | Hematology | Myeloma | Neurology | Peripheral Neuropathy | Velcade